(Q52103175)

22 April 2018

title

Cholinesterase Inhibition in the Scopolamine Model of Dementia (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00231.X

21 November 2022

1 reference

cholinesterase inhibition

1 reference

based on heuristic

inferred from title

history and philosophy of science

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00231.X

21 November 2022

author name string

K. A. Wesnes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

P. M. Simpson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

L. White

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

S. Pinker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

G. Jertz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

M. Murphy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

K. Siegfried

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776749

21 November 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

22 April 2018

full work available at URL

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1991.tb00231.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00231.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1991.tb00231.x/fullpdf

21 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00231.X

Annals of the New York Academy of Sciences

21 November 2022

published in

1 reference

22 April 2018

volume

640

1 reference

22 April 2018

page(s)

268-271

1 reference

22 April 2018

Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

The basis for choice reaction time slowing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

Effects of NMDA Modulation in Scopolamine Dementiaa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

Alzheimer's disease: a correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

The cognitive drug research computerized assessment system for demented patients: A validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1991.TB00231.X

Cognition-enhancing effects of moclobemide, a reversible MAO inhibitor, in humans

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB00231.X

21 November 2022

Identifiers

1 reference

22 April 2018

1 reference

22 April 2018